CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 400 enrolled
Drug / intervention
Comprehensive TB screeningother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02043067
NCT02043067N/ACompleted
CompareCT.gov

Enhanced TB Screening to Determine the Prevalence and Incidence of TB in a Cohort of HIV Clinic Patients in Lusaka, Zambia

University of North Carolina, Chapel Hill·observational·Posted Jan 23, 2014·Updated Sep 15, 2017

In Brief

An observational study evaluating Comprehensive TB screening for Tuberculosis. Completed, enrolled 400 participants across 1 site.

Detailed Summary

This study will examine an enhanced protocol to systematically screen a cohort of 400 new HIV clinic enrollees for prevalence and 1-year incidence of tuberculosis (TB).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTuberculosis
CountriesZambia
CollaboratorsCentre for Infectious Disease Research in Zambia, Centers for Disease Control and Prevention

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 23, 2014
Enrollment StartOct 1, 2011
Primary CompletionSep 1, 2012
Study CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.4 years ago

Interventions

Comprehensive TB screeningother

All enrollees will receive a comprehensive TB screening regardless of symptom presentation.